Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec appointment
confidence 95%
filed 2026-10-23
Item 5.02
Matthew D. Mullet, who already serves as President and Chief Executive Officer of FS Bancorp and its subsidiary bank, has been appointed to the Boards of Directors of both entities effective October 22, 2026. This is a material governance event reflecting the elevation of an existing executive to board-level oversight responsibility. The disclosure emphasizes his extensive leadership experience and the Board's ratification of the appointment, making this a clear exec_appointment event.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-10-23
Item 5.02
Salvatore A. Abbate was appointed President and Chief Executive Officer of LKQ Corporation effective December 15, 2026, succeeding Justin L. Jude who resigned effective October 23, 2026. Abbate's compensation package includes a $1.34M base salary, $3.3M sign-on cash award, $12M sign-on RSUs, and $8M annual PSU target.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-10-23
Item 5.02
The filing discloses both a departure (Tim Wilson stepping down as Manager and President effective October 22, 2026) and an appointment (Michael Considine appointed to the same roles effective the same date). While both events occurred, the appointment of a new Manager and President to lead the company is the principal forward-looking action and the more salient disclosure. The appointment of a top executive to lead a company is material to investors assessing management continuity and operational direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-10-23
Item 5.02
The filing discloses the appointment of Raj Seshadri to Fiserv's board of directors effective November 30, 2026, with detailed background on her qualifications and independence determination. While the section also mentions Henrique De Castro's decision not to stand for re-election, the principal disclosed action centers on the new director appointment. Board composition changes are material to investors assessing governance and strategic direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-23
Item 5.02
Dr. Sheila Gujrathi was appointed as Chief Strategy Officer and to the Board of Directors effective October 23, 2026, in connection with Bolt's acquisition of Prana Therapies.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-10-23
Item 5.02
The filing discloses both the departure of Peter Knag as CFO and the appointment of Andrew Pieper as Interim CFO, effective October 20, 2026. While both events occur, the appointment of a new CFO to assume "principal financial officer and principal accounting officer" roles is the forward-looking material action. The departure is characterized as amicable ("not the result of any disagreement") with transition support, making the appointment the more salient event for investors assessing leadership continuity.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-23
Item 5.02
Jeremy Normington-Slay was appointed to the Boards of Directors of both Civista Bancshares and Civista Bank, effective October 21, 2026. This is a clear board appointment disclosed under Item 5.02, and the appointment of a director with significant executive leadership experience (President and CEO of Firelands Health) to a financial holding company's board is material to investors assessing governance and strategic direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-10-23
Item 5.02
The filing discloses the election of Chelsea Grayson as a Class II director to fill a vacancy created by the Board's increase from eight to nine directors on October 20, 2026. While the section also mentions Martin Taylor's prior resignation (December 19, 2025), the principal action disclosed in this 8-K is the appointment of a new director, making exec_appointment the most salient classification. The disclosure includes her term, independence status, and compensation arrangement ($40,000 monthly cash fee), all material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-10-23
Item 5.02
The filing discloses both departures and appointments of directors and executive officers. Peter Gordon, Marguerite Brogan, and Edward Gellert resigned as directors effective October 23, 2026, while Clark Coffee, Mark Manley, and Alexander Chaloff were appointed as directors on the same date. Additionally, Peter Gordon and Marguerite Brogan resigned as CEO and CFO respectively, with Clark Coffee appointed as CEO and Shane McGrogan appointed as CFO. While both departures and appointments occur, the filing's structure and emphasis center on the new appointments with detailed biographical information for each appointee, making exec_appointment the principal disclosed action. The material leadership transition at a fund manager warrants materiality classification.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-23
Item 5.02
Bio Essence Corp's Board of Directors was expanded from three to ten members through a shareholder-approved bylaw amendment effective October 19, 2026, and two new directors, Thea Zhang and Geoff Fellows, were elected and appointed to the Board.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-10-23
The 6-K discloses the appointment of Mr. (Alfred) Tan Choong Hau as Chief Executive Officer, Chairman, and director of ARB IOT Group Limited, effective October 23, 2026. While the filing also mentions the concurrent resignation of the prior CEO/Chairman Mr. Liew Kok Leong, the principal disclosed action is the appointment of a new executive to fill the vacancies created by that departure. The filing provides extensive biographical detail on Mr. Tan's 25+ years of leadership and technology experience, indicating the Board's confidence in his qualifications. This is a material change in senior leadership at the registrant.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-10-23
Item 5.02
Four directors were elected to the Federal Home Loan Bank of Boston's board, effective January 1, 2027: Christopher J. Logan and Caroline R. Carpenter as member directors, and Duncan Barnard and Robert Tourigny as independent directors.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-10-23
EX-99.1
The disclosure announces the Board-approved appointment of Mr. Akhil Ravi as Head API and Services and Senior Management Personnel, effective November 13, 2026, with induction into the Management Council. Although Ravi is a related party (son-in-law of Co-Chairman G V Prasad), the appointment to a senior management role overseeing a major business unit (Aurigene Pharmaceutical Services Ltd., a wholly owned subsidiary) is a material executive appointment that would affect investor assessment of leadership and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-10-23
Item 5.02
The filing discloses the appointment of Robert Reda as a Board member effective October 19, 2026, with assignments to chair the Nominations Committee and serve on the Audit and Compensation Committees. While the section also mentions Lillian Mbeki's resignation, the principal disclosed action centers on Reda's appointment to the Board. The compensatory arrangements (50,000 shares, annual grants, and $2,500 monthly payment) are ancillary to the appointment itself rather than the primary event.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-22
Item 5.02
Michael L. Olosky was elected to the Board of Directors on October 20, 2026, and appointed to two board committees. Olosky is the current CEO of Simpson Manufacturing and brings relevant executive experience to the board.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-22
Item 5.02
L3Harris appointed Kimberly Fields, Chair, President and CEO of ATI, Inc., to its Board of Directors effective October 21, 2026. The Board increased its authorized size from eleven to twelve directors to accommodate this appointment, recognizing her exceptional track record and proven leadership in manufacturing operations.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-10-22
Item 5.02
Rati Sahi Levesque was appointed to the Board of Directors effective December 1, 2026, and assigned to the Audit & Risk Management Committee, concurrent with the retirement of director Lauri Shanahan.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-10-22
Item 5.02
Julie Shaeff has been appointed to succeed William George as Executive Vice President and Chief Financial Officer, effective upon Mr. George's retirement following the 2026 10-K filing. The appointment represents a planned succession of a critical officer role after George's 30-year tenure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-22
Item 5.02
The filing discloses the appointment of Ryan M. Young as Executive Vice President and Chief Operating Officer of Limoneira, effective November 9, 2026. The principal disclosed action is a person taking a senior operational role. While the disclosure also includes compensatory arrangements (base salary of $560,000, bonus opportunity, equity awards, and change-in-control protections), the core event is the appointment itself. This is material to investors as it represents a significant leadership change in a key operational position.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-22
Item 5.02
The Board of Directors elected James Flanagan as a director of Citigroup and appointed him to the Audit Committee, effective immediately. This is a clear executive appointment event. While the disclosure also mentions his compensation as a non-employee director, the principal action disclosed is his appointment to the Board and Audit Committee, not a compensation arrangement. His extensive background at PwC (nearly 40 years, including COO and Vice Chairman roles) and current board service at other public companies makes this material to investors assessing board composition and audit oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-22
Item 5.02
The Board elected Michael L. Konig as a director on October 19, 2026, filling a vacancy created by increasing the Board from five to six members. Mr. Konig was also appointed to the Compensation Committee and Nominating and Corporate Governance Committee. This is a clear director appointment, the principal disclosed action, and is material as it affects Board composition and governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-10-22
Item 5.02
Following completion of the business combination, Christopher Cooper was appointed Chief Executive Officer and Wray Thorn was appointed President and Chief Financial Officer, with both also elected as directors to establish the new post-merger leadership structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-22
Item 5.02
The filing discloses the appointment of two directors, Dr. Rohit Chitale and Dr. Grigoris Gerotziafas, to the board of directors effective immediately following an Extraordinary Meeting on October 16, 2026. This is a clear executive appointment event under Item 5.02, and board composition changes are material to investors' assessment of governance and strategic direction.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 85%
filed 2026-10-22
The 6-K discloses the appointment of Gary Thomas Dvorchak as an independent director and member of key committees (Compensation, Nominating and Corporate Governance, and chairperson of the latter) effective October 21, 2026. While the filing also mentions the resignation of Alberto Méndez Rebollo and the cessation of Rui Ding as CTO, the principal disclosed action is Dvorchak's appointment to fill the board vacancy and assume committee leadership roles. This is material as it affects board composition and governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-10-22
Item 5.02
Amy Ard was appointed Chief Financial Officer effective October 21, 2026, succeeding Ryan Fiedler. Her compensation package includes a $550,000 base salary, up to 85% bonus, and a $500,000 one-time equity grant.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-22
Item 5.02
The filing discloses the appointment of Peter Radovich as a director of MBX Biosciences effective October 20, 2026, upon recommendation of the Nominating and Corporate Governance Committee. While the disclosure includes compensatory details (stock option grant and cash compensation), the principal disclosed action is the appointment itself—a person taking a board role. This is material as it affects the composition and governance of the company's board of directors.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-22
Item 5.02
MSGS Spinco, Inc. elected eleven directors to its board of directors effective immediately following the spin-off distribution by MSG Sports, establishing the initial board composition of the newly independent public company with directors including Joseph M. Cohen, Stephen C. Mills, Nelson Peltz, Hans Vestberg, and James L. Dolan designated across Class A and Class B stock classes.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-10-22
Item 5.02
The disclosure centers on Stephen C. Ruffini's appointment as Executive Vice President, Mergers & Acquisitions, effective October 16, 2026. While the section is titled "Compensatory Arrangements" and includes detailed compensation terms (base salary of $400,000, bonus and equity targets, severance provisions), the principal disclosed action is the appointment of a named executive to a new officer role. The compensation details are ancillary to the appointment itself.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-10-22
Item 5.02
The filing discloses the appointment of Kenneth J. Anderson to the Board of Directors as a Class III director effective October 17, 2026, filling a vacancy created by Kanat Mynzhanov's resignation on October 16, 2026. While both a departure and appointment occur, the principal disclosed action centers on the appointment of a new director with detailed background information and committee assignments (Audit Committee and Compensation Committee). This is a material governance event affecting board composition.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-10-22
Item 5.02
XCF Global appointed Christopher Cooper as Chairman of the Board, Wray Thorn as President and Chief Financial Officer, and three new directors (Chad J. Langley, John Wharton, and Carl Stanton) effective upon or shortly after the business combination closing. The appointments include employment agreements with base salary, bonuses, and equity grants.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-22
Item 5.02
The filing discloses the appointment of Robert Wong as Vice President, Chief Accounting Officer (Principal Accounting Officer) of Retension Pharmaceuticals, effective November 2, 2026. The principal disclosed action is a person taking a role—a key executive position responsible for accounting and financial reporting. While the filing also includes compensatory details (base salary, bonus, sign-on bonus, and stock options), the core event is the appointment itself, making this an exec_appointment rather than exec_compensation.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-10-22
EX-99.1
The exhibit announces the Board of Directors' appointment of Armando José Cuello Navarro as Executive Vice President of Energy Transition, effective no later than October 27, 2026, as part of Ecopetrol's "New Era" strategy to strengthen senior management. The disclosure also includes appointments of two legal representatives (Camilo Andrés Rojas Castro and Mauricio Gutiérrez Dangond). The appointment of a senior executive officer to a newly created or restructured C-suite position is a material governance event affecting the registrant's leadership structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-22
Item 5.02
Tara Poseley was appointed as a member of lululemon's Board of Directors, effective October 19, 2026, expanding the board from twelve to thirteen members. Her appointment, tied to a cooperation agreement with founder Chip Wilson, reflects her substantial retail and product expertise and prior service as the company's Chief Product Officer.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-22
Item 5.02
Lattice Semiconductor appointed John McCool and Raejeanne Skillern to its Board of Directors effective October 21, 2026, expanding the Board from 8 to 10 directors. Both appointees bring substantial experience in semiconductors, cloud infrastructure, and technology leadership, and will receive annual cash retainers of $80,000 and RSU awards valued at $220,000.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-22
Item 5.02
William Christopher McDougall was appointed by the Board on October 17, 2026, to the positions of Chief Financial Officer, Treasurer, and Assistant Secretary effective immediately, with designation as principal financial officer. This is a clear executive appointment to a material C-suite role. While the disclosure also mentions Bryce D. Klug's continued service as principal accounting officer, the principal disclosed action centers on McDougall's appointment to CFO and related officer positions.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-10-22
Item 5.02
The filing discloses the appointment of Kelsey Cassinelli as Executive Vice President and Chief Financial Officer effective January 1, 2027, following Richard Belstock's retirement from that position. While both a departure and appointment occur, the principal disclosed action centers on the appointment of a new CFO with specified compensation ($300,000 annual base salary) and eligibility for incentive and equity programs. The appointment of a CFO is material to investors' assessment of the company's financial leadership and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-22
Item 5.02
The filing discloses the appointment of Leah Lunger as Chief Accounting Officer, effective November 16, 2026, with an employment agreement dated October 17, 2026. While the disclosure includes compensatory details (base salary of $235,000, stock options, RSUs, and severance terms), the principal disclosed action is the appointment of a named executive officer to a material accounting leadership role. The compensation details are ancillary to the appointment itself.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-10-22
Item 5.02
The filing discloses the appointment of Neil Daniels as Vice President, Chief Accounting Officer effective November 16, 2026, making him the Company's principal accounting officer. While the disclosure also includes compensatory details (base salary of $370,000, sign-on bonus of $175,000, and equity grants), the principal action is the appointment of a named executive to a key accounting role. The appointment of a principal accounting officer is material to investors' assessment of financial reporting oversight and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-10-22
Item 5.02
The filing discloses both the resignation of Michael Blitzer as a director and committee chair and the appointment of Dr. Christopher Scolese as a Class II director with committee assignments. While both events occurred, the principal action emphasized in the Item 5.02 disclosure and press release is the appointment of Dr. Scolese, a highly credentialed former NRO Director and NASA executive, to fill the board vacancy. The appointment of a director with significant government space program experience is material to investors assessing the company's strategic direction and governance.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-10-22
The filing announces the appointment of Chris Rhodes as an independent non-executive director of Lloyds Banking Group plc, effective 1 November 2026, with membership on the Audit Committee and Board Risk Committee. This is a clear executive appointment to the board of a major financial institution, which is material to investors assessing governance and risk oversight.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-10-22
Nigel Hinshelwood, currently Senior Independent Director of the Ring-Fenced Banks, is appointed to join Lloyds Banking Group plc's Board as an independent non-executive director and member of multiple board committees effective 1 November 2026. While the announcement also discloses the departures of Sarah Bentley and Brendan Gilligan on 28 February 2027, the principal disclosed action is the appointment of Hinshelwood to a board role. This is material as it affects board composition and governance at a major financial institution.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-10-22
Item 5.02
Christopher R. Tangard was appointed to the position of Executive Vice President, Chief Financial Officer and Treasurer, effective March 2, 2027, succeeding Bryan P. Petrucelli.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-10-22
Item 5.02
The filing discloses the appointment of Ross Moat as President and Chief Operating Officer effective immediately on October 17, 2026. While the disclosure also includes compensation adjustments (salary increase from $650,000 to $700,000 and bonus target increase from 55% to 60%), the principal action is the promotion to a new executive title. The appointment of an officer to a senior C-suite role is material to investors assessing company leadership and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-21
Item 5.02
Jeffrey M. Stutz was appointed as Chief Executive Officer and Board member, effective October 21, 2026, following his service as Interim CEO since June 2026. The appointment includes compensatory arrangements comprising a base salary of $1,000,000, equity grants, and severance terms.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-21
Item 5.02
Bank of America's Board appointed two seasoned executives—James Fitterling (former CEO of Dow Inc.) and William Thomas (former Global CEO of KPMG International)—as directors effective immediately, expanding the Board from 12 to 14 members. The disclosure centers on the appointment action itself, with committee assignments and compensation details following. This is a material governance event affecting board composition at a major financial institution.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-10-21
Item 5.02
The filing discloses the appointment of Luc Tack as a director of FMC Corporation effective October 21, 2026, following the company's sale of 30.3 million shares to Tessenderlo Group NV (the Investor) in September 2026. The appointment was required under the Investor Agreement and represents a material governance change tied to the significant equity transaction. While the disclosure also mentions director compensation arrangements, the principal disclosed action is Tack's appointment to the Board and a committee, making this an exec_appointment event.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-10-21
EX-99.1
Marc Fontaine has been appointed to Vertical Aerospace's Board of Directors effective 21 October 2026. This is the third senior aerospace and defence appointment in recent weeks, following the appointment of former Airbus Commercial Aircraft CEO Fabrice Brégier as Chair and former Leonardo Helicopters U.S. CEO Clyde Woltman as a director. The appointment of a seasoned aerospace executive with over two decades at Airbus to the board during a critical phase of aircraft certification and commercialization is material to investors assessing the company's governance and execution capability.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-10-21
Item 5.02
The filing discloses the appointment of Kaz Nejatian as President of Opendoor Technologies, effective October 21, 2026, in addition to his existing roles as CEO and Board member. While the section also describes Lucas Matheson's departure from the President role and his transition to an Advisor position with severance protections, the principal disclosed action centers on the appointment of Nejatian to the President role. This is material as it represents a significant change in executive leadership structure and reporting relationships.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-10-21
Item 5.02
Allen Kaplan was elected Chief Financial Officer effective November 1, 2026, with a base salary of $280,000, performance bonus, supplemental bonus, and equity awards (RSUs and PSUs). The appointment was announced via press release and represents a material transition in senior financial leadership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-21
Item 7.01
Brian Krzanich (former Intel and CDK Global executive) and Gary Ferrera (30+ years of CFO experience) were appointed to the Board of Directors effective October 14, 2026.
View raw filing on EDGAR →